Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.8.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Revenue $ 152,312 $ 172,121 $ 129,656
Cost of sales 101,394 116,250 86,366
Restructuring costs 9,256    
Total cost of sales 110,650 116,250 86,366
Gross profit 41,662 55,871 43,290
Operating expenses:      
Selling, general and administrative 44,030 39,408 32,179
Research and development 3,712 2,372 2,475
Amortization and depreciation 6,068 6,115 4,868
Acquisition, severance and transition costs 6,096 3,851 1,950
Stock-based compensation 2,976 2,141 2,719
Impairment of goodwill 10,702    
Impairment of intangible assets 10,480    
Restructuring costs 7,652    
Total operating expenses 91,716 53,887 44,191
Operating income (loss) (50,054) 1,984 (901)
Interest expense and other charges (3,853) (2,506) (1,481)
Net loss $ (53,907) $ (522) $ (2,382)
Net loss per share, basic and diluted $ (2.59) $ (0.03) $ (0.16)
Weighted average shares outstanding, basic and diluted 20,847 19,034 14,930